Table 1 Adrenalectomy findings in patients with hyperaldosteronism
Case | Age | Gender | Medication (duration) | Adrenalectomy diagnosis | Spironolactone-like bodies present |
|---|---|---|---|---|---|
1 | 39 | M | Spironolactone (6 weeks), Eplerenone (6 weeks with no treatment 3 weeks prior to surgery) | Adrenal cortical adenoma (1.9 cm) | Diffuse |
2 | 59 | F | Spironolactone (>9 months) | Adrenal cortical adenoma (0.9 cm) | Diffuse |
3 | 56 | M | Spironolactone (>9 months) | Adrenal cortical adenoma (2.8 cm) | Focal |
4 | 61 | M | Spironolactone (>2 months) | Nodular cortical hyperplasia | Focal |
5 | 35 | M | Spironolactone (5 months) | Adrenal cortical adenoma (1.8 cm) | None |
6 | 60 | M | Spironolactone (2 months with no treatment 7 months prior to surgery) | Nodular cortical hyperplasia | None |
7 | 68 | M | Spironolactone (>2 months) | Vascular cyst | None |
8 | 60 | M | Eplerenone (>3 years) | Adrenal cortical adenoma (1.6 cm) | None |
9 | 48 | M | Eplerenone (>3 months) | Nodular cortical hyperplasia | None |
10 | 51 | M | Eplerenone (>3 years) | Nodular cortical hyperplasia | None |
11 | 46 | M | Eplerenone (>1.5 years) | Hematoma (post venus sampling) | None |
12 | 46 | M | Eplerenone (unknown) | Lipoma | None |
13 | 43 | F | No treatment | Adrenal cortical adenoma (2.3 cm) | None |
14 | 34 | F | No treatment | Adrenal cortical adenoma (1.5 cm) | None |
15 | 62 | M | No treatment | Adrenal cortical adenoma (2.3 cm) | None |